Andreas Parkner

Author PubWeight™ 0.81^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Clinically relevant doses of FLT3-kinase inhibitors quizartinib and midostaurin do not impair T-cell reactivity and function.	Haematologica	2014	0.81